KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $7.1 billion.

  • Amgen's Operating Expenses rose 547.6% to $7.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.7 billion, marking a year-over-year increase of 575.17%. This contributed to the annual value of $27.7 billion for FY2025, which is 575.17% up from last year.
  • Amgen's Operating Expenses amounted to $7.1 billion in Q4 2025, which was up 547.6% from $7.0 billion recorded in Q3 2025.
  • Amgen's 5-year Operating Expenses high stood at $7.1 billion for Q4 2025, and its period low was $3.7 billion during Q1 2022.
  • Over the past 5 years, Amgen's median Operating Expenses value was $5.3 billion (recorded in 2021), while the average stood at $5.5 billion.
  • In the last 5 years, Amgen's Operating Expenses plummeted by 2246.4% in 2022 and then soared by 5430.21% in 2024.
  • Quarter analysis of 5 years shows Amgen's Operating Expenses stood at $4.5 billion in 2021, then increased by 1.48% to $4.6 billion in 2022, then surged by 50.25% to $6.9 billion in 2023, then decreased by 2.17% to $6.8 billion in 2024, then rose by 5.48% to $7.1 billion in 2025.
  • Its Operating Expenses was $7.1 billion in Q4 2025, compared to $7.0 billion in Q3 2025 and $6.5 billion in Q2 2025.